[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

DK3302573T3 - Sammensætning til behandlingen af hjernelæsioner - Google Patents

Sammensætning til behandlingen af hjernelæsioner Download PDF

Info

Publication number
DK3302573T3
DK3302573T3 DK16727364T DK16727364T DK3302573T3 DK 3302573 T3 DK3302573 T3 DK 3302573T3 DK 16727364 T DK16727364 T DK 16727364T DK 16727364 T DK16727364 T DK 16727364T DK 3302573 T3 DK3302573 T3 DK 3302573T3
Authority
DK
Denmark
Prior art keywords
lessions
brain
treatment
composition
brain lessions
Prior art date
Application number
DK16727364T
Other languages
English (en)
Inventor
Myriam Bernaudin
Omar Touzani
Marie-Sophie Quittet
Denis Barritault
Jérôme Toutain
Original Assignee
Organes Tissus Regeneration Reparation Remplacement
Denis Barritault
Luniversite De Caen Basse Normandie
Centre Nat Rech Scient
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Organes Tissus Regeneration Reparation Remplacement, Denis Barritault, Luniversite De Caen Basse Normandie, Centre Nat Rech Scient filed Critical Organes Tissus Regeneration Reparation Remplacement
Application granted granted Critical
Publication of DK3302573T3 publication Critical patent/DK3302573T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/721—Dextrans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/15—Cells of the myeloid line, e.g. granulocytes, basophils, eosinophils, neutrophils, leucocytes, monocytes, macrophages or mast cells; Myeloid precursor cells; Antigen-presenting cells, e.g. dendritic cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/35—Fat tissue; Adipocytes; Stromal cells; Connective tissues
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DK16727364T 2015-05-28 2016-05-26 Sammensætning til behandlingen af hjernelæsioner DK3302573T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP15305806.0A EP3097928A1 (fr) 2015-05-28 2015-05-28 Composition pour le traitement des lesions cerebrales
PCT/EP2016/061905 WO2016189087A1 (fr) 2015-05-28 2016-05-26 Composition pour le traitement des lesions cerebrales

Publications (1)

Publication Number Publication Date
DK3302573T3 true DK3302573T3 (da) 2019-11-11

Family

ID=53276045

Family Applications (1)

Application Number Title Priority Date Filing Date
DK16727364T DK3302573T3 (da) 2015-05-28 2016-05-26 Sammensætning til behandlingen af hjernelæsioner

Country Status (17)

Country Link
US (1) US20180161372A1 (da)
EP (2) EP3097928A1 (da)
JP (1) JP6879941B2 (da)
KR (1) KR20180043208A (da)
CN (1) CN107864626A (da)
AU (1) AU2016266772A1 (da)
CA (1) CA2992899A1 (da)
DK (1) DK3302573T3 (da)
ES (1) ES2755053T3 (da)
IL (1) IL255692B (da)
MX (1) MX2017015292A (da)
PL (1) PL3302573T3 (da)
PT (1) PT3302573T (da)
RU (1) RU2710543C2 (da)
SI (1) SI3302573T1 (da)
WO (1) WO2016189087A1 (da)
ZA (1) ZA201707737B (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3097922A1 (fr) * 2015-05-28 2016-11-30 Denis Barritault Composition pour le traitement des lesions tissulaires
WO2019237106A1 (en) * 2018-06-08 2019-12-12 University Of Virginia Patent Foundation Compositions and methods for treating stroke
FR3096579B1 (fr) 2019-05-27 2023-05-05 Organes Tissus Regeneration Reparation Remplacement composition pour la protection et la reparation de la barriere hematoencephalique (BHE)
AU2021235223A1 (en) * 2020-03-09 2022-09-29 Denis Barritault Composition for the treatment of lesions of the respiratory system
CN114317421B (zh) * 2021-12-16 2024-05-03 北京科技大学 强化间充质干细胞促进血管生成的方法、组合物及应用
WO2024124507A1 (en) * 2022-12-15 2024-06-20 Center For Excellence In Brain Science And Intelligence Technology, Chinese Academy Of Sciences Striatal neural progenitors in treatment of hypoxic-ischemic encephalopathy

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6573251B2 (en) * 1994-03-30 2003-06-03 Denis Barritault Drug and pharmaceutical composition for the treatment of lesions of the nervous system and fractions enriched in heparan sulfate
FR2781485B1 (fr) * 1998-07-21 2003-08-08 Denis Barritault Polymeres biocompatibles leur procede de preparation et les compositions les contenant
EP1513404A4 (en) * 2002-05-30 2006-01-04 Myocardial Therapeutics Inc INTRAMYOCARDIAL INJECTIONS OF AUTOLOGOUS BONE MARROW
US20060104968A1 (en) * 2003-03-05 2006-05-18 Halozyme, Inc. Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminogly ycanases
FR2979110B1 (fr) * 2011-08-16 2013-09-27 Etat Francais Ministere De La Defense Service De Sante Des Armees Modelisation in vitro des niches medullaires a cellules souches hematopoietiques : un outil pour etudier la regulation de l'hematopoiese, evaluer le potentiel de nichage d'un greffon hematopoietique et tester la pharmaco-toxicologie de medicaments.

Also Published As

Publication number Publication date
KR20180043208A (ko) 2018-04-27
AU2016266772A1 (en) 2017-12-14
MX2017015292A (es) 2018-05-02
RU2017139945A (ru) 2019-06-28
IL255692A (en) 2018-01-31
PL3302573T3 (pl) 2020-03-31
ZA201707737B (en) 2018-11-28
US20180161372A1 (en) 2018-06-14
CA2992899A1 (fr) 2016-12-01
EP3302573B1 (fr) 2019-09-11
JP2018516258A (ja) 2018-06-21
CN107864626A (zh) 2018-03-30
EP3302573A1 (fr) 2018-04-11
WO2016189087A1 (fr) 2016-12-01
JP6879941B2 (ja) 2021-06-02
SI3302573T1 (sl) 2019-12-31
RU2017139945A3 (da) 2019-09-04
IL255692B (en) 2021-02-28
ES2755053T3 (es) 2020-04-21
EP3097928A1 (fr) 2016-11-30
RU2710543C2 (ru) 2019-12-27
PT3302573T (pt) 2019-10-29

Similar Documents

Publication Publication Date Title
DK3377516T3 (da) Sammensætning til behandling af cancer
DK3173092T3 (da) Rna-holdig sammensætning til behandling af tumorsygdomme
DK3192902T3 (da) Fremgangsmåde til fremstilling af graphenholdige viscosefibre
DK3143025T3 (da) Forbindelser til behandling af spinal muskelatrofi
DK3286311T3 (da) Fremgangsmåde til behandling af maligniteter
DK3125875T3 (da) Inhalerbar rapamycinformulering til behandling af aldersrelaterede tilstande
DK3185876T3 (da) Sammensætninger og fremgangsmåder til behandling af neurologiske lidelser
DK3096741T3 (da) Fremgangsmåde til fremstillingen af hybridosomer
DK3325443T3 (da) Fremgangsmåde til fremstilling af pridopidin
DK3102673T3 (da) Fremgangsmåder og sammensætninger til behandling af beta-talassæmi
DK3240612T3 (da) Fremgangsmåder til behandling af nethindesygdomme
DK3148529T3 (da) Forbindelser til behandling af hjernecancer
DK3174858T3 (da) Fremgangsmåde til fremstilling af pyrazoler
DK3362066T3 (da) Kombinationsterapi til behandling af maligniteter
DK3524255T3 (da) Sammensætning til behandling af acne
DK3317400T3 (da) Fremgangsmåde til kryokonservering af tumorinfiltrerende lymfocytter
DK3390390T3 (da) Bipyrazolylderivater egnede til behandling af autoimmunsygdomme
DK3265087T3 (da) Fremgangsmåde til behandling med tradipitant
DK3233813T3 (da) Fremgangsmåder til fremstilling af oxathiazin-lignende forbindelser
DK3307267T3 (da) Behandling af multipel sklerose
DK3318115T3 (da) Maskine til behandling af svinegylle
DK3280408T3 (da) Fremgangsmåde til fremstilling af dicycloplatin
DK3261661T3 (da) Menotropin til behandling af infertilitet
DK3302573T3 (da) Sammensætning til behandlingen af hjernelæsioner
DK3192524T3 (da) Hgf præparat egnet til behandling af neurologiske lidelser